Mitochondrial metabolism and macrophage function post MI

心肌梗死后线粒体代谢和巨噬细胞功能

基本信息

  • 批准号:
    10630833
  • 负责人:
  • 金额:
    $ 69.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

Abstract Macrophages are key components of innate immunity system. It emerged recently that macrophages play critical roles in heart health and diseases. Following myocardial infarction (MI), macrophage is recruited in high number to the infarct site and acts as a key regulator in post-MI remodeling, generating proinflammatory signals early and reparative cues later. However, it is not well understood how macrophage function is regulated during the period of rapid change. Of interest, transcriptome analysis of macrophage in the infarct zone showed a time- dependent reprogramming of mitochondrial function during the first week post-MI when macrophage phenotype transitions from proinflammatory to reparative. This raises the question whether mitochondrial metabolism in macrophage is causally linked to the outcome of post-MI remodeling, and if so, what the underlying mechanisms are. Immunology research finds that macrophage activation is accompanied by global rewiring of the metabolic pathway. Proinflammatory macrophage, elicited by Toll-like receptor ligands lipopolysaccharide (LPS), shifts it energy metabolism from oxidative phosphorylation towards glycolysis. Such a metabolic switch is thought to favor rapid energy production and increased demand for biosynthesis, and fuel pentose phosphate pathway for NADPH generation, all lead to high levels of ROS and proinflammatory cytokines. On the other hand, the Th2 cytokines IL-4 and IL-13 induce alternative activation which promotes anti-inflammatory activity, wound healing and tissue repair, and presents the opposite metabolic pattern. Although the metabolic switch has been well described, questions remain whether differential metabolic activity (i.e., use of glycolysis versus mitochondrial respiration) is a coincidence, a consequence of changes in phenotype, or a direct driver of macrophage function. It is also unclear whether similar mechanisms apply to cardiac macrophages. To decipher the mechanistic role of mitochondrial function in macrophage phenotype, we analyzed the phenotype of macrophage with impaired mitochondrial respiration due to deletion of Ndufs4, a mitochondrial Complex I protein (KO). KO increased glycolysis and reduced oxygen consumption in bone marrow derived macrophage (BMDM), and demonstrated exacerbated inflammatory response to LPS stimulation. In mice with myeloid-specific deletion of Ndufs4 (mKO) we showed increased mortality and poor cardiac function after MI. These observations led us to hypothesize that mitochondrial function is a key regulator of macrophage polarization during post-MI remodeling and hence a potential therapeutic target. To test the hypothesis, we will investigate the mechanistic link between mitochondrial function and epigenetic reprogramming during stimulation in primary macrophages, and furthermore, test the effects of manipulating mitochondrial function in macrophage function and post-MI remodeling in mice.
摘要

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Role of Innate Immune Cells in Cardiac Injury and Repair: A Metabolic Perspective.
  • DOI:
    10.1007/s11886-023-01897-4
  • 发表时间:
    2023-07
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Banerjee, Durba;Tian, Rong;Cai, Shanshan
  • 通讯作者:
    Cai, Shanshan
Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes.
  • DOI:
    10.1172/jci139828
  • 发表时间:
    2022-03-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wu J;Singh K;Lin A;Meadows AM;Wu K;Shing V;Bley M;Hassanzadeh S;Huffstutler RD;Schmidt MS;Blanco LP;Tian R;Brenner C;Pirooznia M;Kaplan MJ;Sack MN
  • 通讯作者:
    Sack MN
Boosting mitochondrial metabolism with dietary supplements in heart failure.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rong Tian其他文献

Rong Tian的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rong Tian', 18)}}的其他基金

Mitochondrial metabolism and macrophage function post MI
心肌梗死后线粒体代谢和巨噬细胞功能
  • 批准号:
    10421059
  • 财政年份:
    2020
  • 资助金额:
    $ 69.62万
  • 项目类别:
Mitochondrial function and glycolytic switch in pathological cardiac hypertrophy
病理性心脏肥大中的线粒体功能和糖酵解转换
  • 批准号:
    9925814
  • 财政年份:
    2018
  • 资助金额:
    $ 69.62万
  • 项目类别:
Fatty acid oxidation suppresses cardiac hypertrophy
脂肪酸氧化抑制心脏肥大
  • 批准号:
    9100917
  • 财政年份:
    2015
  • 资助金额:
    $ 69.62万
  • 项目类别:
Fatty acid oxidation suppresses cardiac hypertrophy
脂肪酸氧化抑制心脏肥大
  • 批准号:
    8977407
  • 财政年份:
    2015
  • 资助金额:
    $ 69.62万
  • 项目类别:
Glucose And BCAA Metabolism in the Heart
心脏中的葡萄糖和支链氨基酸代谢
  • 批准号:
    9035425
  • 财政年份:
    2014
  • 资助金额:
    $ 69.62万
  • 项目类别:
Glucose And BCAA Metabolism in the Heart
心脏中的葡萄糖和支链氨基酸代谢
  • 批准号:
    8711853
  • 财政年份:
    2014
  • 资助金额:
    $ 69.62万
  • 项目类别:
Glucose And BCAA Metabolism in the Heart
心脏中的葡萄糖和支链氨基酸代谢
  • 批准号:
    8822324
  • 财政年份:
    2014
  • 资助金额:
    $ 69.62万
  • 项目类别:
Glucose And BCAA Metabolism in the Heart
心脏中的葡萄糖和支链氨基酸代谢
  • 批准号:
    9256515
  • 财政年份:
    2014
  • 资助金额:
    $ 69.62万
  • 项目类别:
Complex I Deficiency Triggered Acceleration of Heart Failure
复合物 I 缺乏会加速心力衰竭
  • 批准号:
    8676927
  • 财政年份:
    2011
  • 资助金额:
    $ 69.62万
  • 项目类别:
Complex I Deficiency Triggered Acceleration of Heart Failure
复合物 I 缺乏会加速心力衰竭
  • 批准号:
    8318138
  • 财政年份:
    2011
  • 资助金额:
    $ 69.62万
  • 项目类别:

相似海外基金

Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10590611
  • 财政年份:
    2022
  • 资助金额:
    $ 69.62万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中的骨-脂肪相互作用
  • 批准号:
    10706006
  • 财政年份:
    2022
  • 资助金额:
    $ 69.62万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10368975
  • 财政年份:
    2021
  • 资助金额:
    $ 69.62万
  • 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
  • 批准号:
    10365254
  • 财政年份:
    2021
  • 资助金额:
    $ 69.62万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10202896
  • 财政年份:
    2021
  • 资助金额:
    $ 69.62万
  • 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
  • 批准号:
    10531570
  • 财政年份:
    2021
  • 资助金额:
    $ 69.62万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10541847
  • 财政年份:
    2019
  • 资助金额:
    $ 69.62万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10319573
  • 财政年份:
    2019
  • 资助金额:
    $ 69.62万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10062790
  • 财政年份:
    2019
  • 资助金额:
    $ 69.62万
  • 项目类别:
Promotion of NAD+ anabolism to promote lifespan
促进NAD合成代谢以延长寿命
  • 批准号:
    DE170100628
  • 财政年份:
    2017
  • 资助金额:
    $ 69.62万
  • 项目类别:
    Discovery Early Career Researcher Award
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了